Aclarion, Inc. (ACON)
6.44
+0.33
(+5.40%)
USD |
NASDAQ |
Dec 12, 16:00
6.50
+0.06
(+0.93%)
After-Hours: 20:00
Aclarion EPS Diluted (Quarterly): -2.930 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spok Holdings, Inc. | 0.1523 |
| DarioHealth Corp. | -3.052 |
| National Research Corp. | 0.1805 |
| Predictive Oncology, Inc. | -107.25 |
| GoodRx Holdings, Inc. | 0.0032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.706M |
| Revenue (Quarterly) | 0.0189M |
| Total Expenses (Quarterly) | 1.725M |
| Enterprise Value | -7.616M |
| Gross Profit Margin (Quarterly) | -285.7% |
| Profit Margin (Quarterly) | -9.03K% |
| Earnings Yield | -24.89K% |
| Normalized Earnings Yield | -24098.46 |